Time to Onset of Efficacy of Cannabidiol (CBD) During Titration in Patients with Lennox-Gastaut Syndrome or Dravet Syndrome Enrolled in Three Randomised Controlled Trials

Neuropediatrics 2019; 50(S 02): S1-S55
DOI: 10.1055/s-0039-1698214

Poster Presentations

Poster Area GNP Epilepsy 1

Georg Thieme Verlag KG Stuttgart · New York

Maria Mazurkiewicz-Beldzinska

¹Medical University of Gdańsk, Department of Developmental Neurology, Gdańsk, Poland

,

Michael Privitera

²University of Cincinnati Medical Center, Neurology & Rehabilitation Medicine, Cincinnati, Ohio, United States

,

Eric Marsh

³The Children’s Hospital of Philadelphia, Division of Neurology, Philadelphia, Pennsylvania, United States

,

Vicente Villanueva

⁴University and Polytechnic Hospital La Fe, Neurology Service, Valencia, Spain

,

Kevan VanLandingham

⁵Greenwich Biosciences, Inc., Neurology, Carlsbad, California, United States

,

Daniel Checketts

⁶GW Research Ltd, Neurology, Cambridge, United Kingdom

,

Volker Knappertz

⁵Greenwich Biosciences, Inc., Neurology, Carlsbad, California, United States